This retrospective study was undertaken to investigate the safety and efficacy of low atropine concentrations of 0.01% and 0.05% with every other day instillation, for slowing down progression of myopia in children and adolescents. There were 92 eyes of 46 myopic children with myopia ranging from -1 to -8D, astigmatism <-2.50D and progression of at least 1D over the past year. Group 1 of 0.01% had 22 children and group 2 of 0.05% had 24 children. All had 12 months follow-up. There were no significant differences in baseline measurements between groups. At 12 months, mean spherical equivalent changes were -0.41 0.28D in group 1 and -0.19 ±0.22D in group 2. These changes were significant.
Atropine dosage for myopia treatment
Reviewed by Fiona Rowe
One-year results of 0.01% and 0.05% atropine eye drops in childhood myopic progression.
CONTRIBUTOR
Fiona Rowe (Prof)
Institute of Population Health, University of Liverpool, UK.
View Full Profile
